To our knowledge, this is the third case of Kaposi's sarcoma diagnosed under rituximab in a HIV-negative patient, the first one at the rectal level and the first one that completely regresses after stop of rituximab. This case raises awareness of iatrogenic Kaposi's sarcoma in HIV-negative patients treated with rituximab, and further highlights the importance of immunosuppression in the pathophysiology of disease.
Keyphrases
- antiretroviral therapy
- diffuse large b cell lymphoma
- hiv positive
- hiv testing
- hiv infected
- human immunodeficiency virus
- hiv aids
- hepatitis c virus
- chronic lymphocytic leukemia
- men who have sex with men
- hodgkin lymphoma
- ulcerative colitis
- case report
- rectal cancer
- high glucose
- diabetic rats
- oxidative stress
- endothelial cells